Joint detection kit for alpha,beta-thalassemia associated mutant genes
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 潮州凯普生物化学有限公司
- Publication Date
- 2011-09-14
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of genes, in particular to a combined detection kit for α, β-thalassemia mutation genes. Background technique
[0002] Thalassemia (hereinafter referred to as thalassemia) is a hemolytic anemia caused by an imbalance in the synthesis rate of α, β-globin peptide chains due to human gene mutation or deletion. Thalassemia is one of the most common genetic diseases in the world, and it is widely distributed in Mediterranean countries and other areas where malaria used to be high. In my country, the provinces south of the Yangtze River have a high incidence rate. In addition to the highest incidence rates in Guangdong, Guangxi, and Hainan provinces, Guizhou, Yunnan, and Sichuan are also high-incidence areas. The two common types of thalassemia are alpha-thalassemia and beta-thalassemia.
[0003] α-thalassemia is a chronic hemolytic disease caused by autosomal genetic defect, which causes the loss or dysfunction of α-glob...